Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow

Branched DNA (bDNA) assays to quantify human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) consist of three distinct steps, including sample processing, hybridization, and detection, and utilize the System 340 platform for plate incubation and washing. Sample processing differs:...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Microbiol
Glavni autori: Elbeik, Tarek, Markowitz, Norman, Nassos, Patricia, Kumar, Uday, Beringer, Scott, Haller, Barbara, Ng, Valerie
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2004
Teme:
Virology
Online pristup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC446273/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15243070/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.42.7.3120-3127.2004
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items